N-glycan profiling as a risk stratification biomarker for type 2 diabetes

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

This study sets out to establish an N-glycan biomarker profile of suboptimal health in a well-established cohort of adult Australians, the Busselton Healthy Ageing Study (BHAS) and Chinese (SHS cohort) . This biomarker profile will contribute to the future development of N-glycan traits as a tool for (i) risk prediction of chronic disease onset, in particular those chronic conditions that constitute type II diabetes mellitus, and (ii) the prediction of a patient’s response to treatment.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2020

Funding Scheme: Targeted Calls

Funding Amount: $549,644.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical Biochemistry: Carbohydrates

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

biomarkers | diabetes | diabetes prevention | preventive medicine | public health